Floatz logo

Glubran 2

Pancreatic Fistula

Minia UniversityPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Pancreatic Fistula cohort.

Asset / SponsorPhaseRating
Solu-Cortef
Helsinki University Central Hospital
Phase 4B
Pasireotide
Helsinki University Central Hospital
Phase 4B
NORMAL HUMAN SERUM ALBUMIN
Universiti Kebangsaan Malaysia Medical Centre
Phase 2CCC

Same molecule, other indications

Glubran 2 is also rated in:

malignant pancreatic neoplasmDormant
CCC
Indicative ·
51 / 100
View asset →
pancreatic ductal adenocarcinomaDormant
CCC
Indicative ·
48 / 100
View asset →
periampullary adenocarcinomaDormant
NR
Indicative ·
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →